MCID: HRP004
MIFTS: 60

Herpes Zoster malady

Categories: Skin diseases, Infectious diseases, Neuronal diseases

Aliases & Classifications for Herpes Zoster

About this section

Aliases & Descriptions for Herpes Zoster:

Name: Herpes Zoster 10 46 47 12 36 2
Shingles 10 46 35 2
 
Herpes Zoster Disease 65
Herpes Zona 10

Classifications:



External Ids:

Disease Ontology10 DOID:8536
ICD1027 B02, B02.9
ICD9CM29 053
MeSH36 D006562
NCIt42 C71079
UMLS65 C0019360

Summaries for Herpes Zoster

About this section
MedlinePlus:35 Shingles is a disease caused by the varicella-zoster virus - the same virus that causes chickenpox. after you have chickenpox, the virus stays in your body. it may not cause problems for many years. as you get older, the virus may reappear as shingles. although it is most common in people over age 50, anyone who has had chickenpox is at risk. you can't catch shingles from someone who has it. however, if you have a shingles rash, you can pass the virus to someone who has never had chickenpox. this would usually be a child, who could get chickenpox instead of shingles. the virus spreads through direct contact with the rash, and cannot spread through the air. early signs of shingles include burning or shooting pain and tingling or itching, usually on one side of the body or face. the pain can be mild to severe. rashes or blisters appear anywhere from one to 14 days later. if shingles appears on your face, it may affect your vision or hearing. the pain of shingles may last for weeks, months, or even years after the blisters have healed. there is no cure for shingles. early treatment with medicines that fight the virus may help. these medicines may also help prevent lingering pain. a vaccine may prevent shingles or lessen its effects. the vaccine is recommended for people 60 or over. in some cases doctors may give it to people ages 50 to 59. nih: national institute of allergy and infectious diseases

MalaCards based summary: Herpes Zoster, also known as shingles, is related to rheumatoid arthritis and cryoglobulinemia, and has symptoms including rash which is followed by blisters, headache and fever. An important gene associated with Herpes Zoster is DPYD (Dihydropyrimidine Dehydrogenase), and among its related pathways are Immune response_MIF-mediated glucocorticoid regulation and IL12 signaling mediated by STAT4. The drugs capsaicin and capsicum oleoresin have been mentioned in the context of this disorder. Affiliated tissues include nerve fiber, skin and eye.

Disease Ontology:10 A viral infectious disease that results in infection located in nerve fiber, has material basis in Human herpesvirus 3, which reactivates after appearing as chickenpox in childhood. The virus is transmitted by direct contact with the rash, which can develop into chickenpox in newly-infected individuals. The infection has symptom rash which is followed by blisters, has symptom headache, has symptom fever, has symptom malaise, has symptom itching, has symptom burning pain, and has symptom paresthesia.

CDC:2 Shingles, also known as zoster or herpes zoster, is a painful skin rash. It is caused by varicella zoster virus (VZV), the same virus that causes chickenpox. Nearly 1 out of every 3 people in the United States will develop shingles in their lifetime. Anyone who has had chickenpox or received chickenpox vaccine in the past may develop shingles. Even children can get shingles. However, the risk of getting the disease increases as you get older. About half of all cases occur in men and women who are 60 years old or older...

NINDS:46 Shingles (herpes zoster) is an outbreak of rash or blisters on the skin that is caused by the same virus that causes chickenpox ? the varicella-zoster virus. The first sign of shingles is often burning or tingling pain (which can be severe), or sometimes numbness or itch,generally on one side of the body. After several days or a week, a rash of fluid-filled blisters, similar to chickenpox, appears in one area on one side of the body. Shingles pain can be mild or intense.

Wikipedia:68 Shingles, also known as zoster, herpes zoster, or zona, is a viral disease characterized by a painful... more...

Related Diseases for Herpes Zoster

About this section

Diseases related to Herpes Zoster via text searches within MalaCards or GeneCards Suite gene sharing:

(show top 50)    (show all 342)
idRelated DiseaseScoreTop Affiliating Genes
1rheumatoid arthritis29.8HLA-B, IFNG, IL10, IL2
2cryoglobulinemia29.5CD8A, IFNG, IL2
3neurogenic bladder29.2CCR5, IFNG, IL10, IL2
4systemic lupus erythematosus29.1FCGR3A, IFNG, IL10, IL2
5geniculate herpes zoster12.5
6herpes zoster ophthalmicus12.5
7postherpetic neuralgia11.2
8maculopapular lupus rash10.7IFNA2, IL10
9pharyngitis10.6IL10, TMPO
10enophthalmos10.6CD8A, IFNA2
11achalasia10.6CD8A, IL10
12shigellosis10.6IFNA2, TMPO
13geniculate ganglionitis10.6
14cycloplegia10.5IFNG, IL10
15dioctophymiasis10.5IFNG, IL10
16opisthorchiasis10.5IFNG, IL10
17lymphocytic choriomeningitis10.5CD8A, HLA-B
18buruli ulcer10.5IFNG, IL10
19autosomal recessive type iv ehlers-danlos syndrome10.5IFNA2, IFNG
20epidemic pleurodynia10.5IFNG, IL10
21neurotic disorder10.5IFNG, IL10
22streptococcal meningitis10.5CD8A, IL10
23cow milk allergy10.5IFNG, IL10
24polycystic echinococcosis10.5HLA-B, IL10
25early-onset, autosomal dominant alzheimer disease10.5IFNG, IL10
26hydronephrosis10.5IFNG, IL10
27aniseikonia10.5CD8A, IL10
28internal hordeolum10.5CD8A, IFNA2
29paget disease of bone 410.4IL10, IL2
30pulmonary nodular lymphoid hyperplasia10.4HLA-B, IFNG
31hemorrhagic proctocolitis10.4IFNG, IL10
32dancing eyes-dancing feet syndrome10.4IFNG, IL10
33peritoneal cystic mesothelioma10.4IFNG, IL10
34ureterocele10.4CD8A, IL2
35congenital dyserythropoietic anemia10.4CD8A, IFNG
36kernicterus due to isoimmunization10.4HLA-B, IFNA2, IL10
37cryptosporidiosis10.4HLA-B, IFNG
38peripheral retinal degeneration10.4IFNG, IL10
39sarcocystosis10.4DPYD, HLA-B, IL10
40limbic encephalitis with ncmags antibodies10.3IFNG, IL2
41vein disease10.3CD8A, GYPC
42trench fever10.3IFNG, IL10
43soft palate cancer10.3CD8A, IFNG
44astrakhan spotted fever10.3IFNG, IL10
45collagenous colitis10.3IFNG, IL2
46ophthalmoplegia10.3
47abdominal tuberculosis10.3IFNG, IL10
48cholera10.3CD8A, HLA-B, IL10
49vagus nerve neoplasm10.3IFNG, IL10
50argentine hemorrhagic fever10.3IFNG, IL2

Graphical network of the top 20 diseases related to Herpes Zoster:



Diseases related to herpes zoster

Symptoms for Herpes Zoster

About this section

Symptoms:

 10 (show all 7)
  • rash which is followed by blisters
  • headache
  • fever
  • malaise
  • itching
  • burning pain
  • paresthesia

UMLS symptoms related to Herpes Zoster:


sleeplessness, equilibration disorder, vertigo/dizziness, chronic pain, tremor, syncope, seizures, sciatica, pruritus, pain, headache, exanthema, back pain

Drugs & Therapeutics for Herpes Zoster

About this section

Drugs for Herpes Zoster (from DrugBank, HMDB, Dgidb, PharmGKB, IUPHAR, NovoSeek, BitterDB):

(show top 50)    (show all 323)
idNameStatusPhaseClinical TrialsCas NumberPubChem Id
1
TofacitinibapprovedPhase 4, Phase 295477600-75-2
Synonyms:
Tasocitinib
 
Tofacitinib Citrate
Tofacitinibum
Xeljanz
2
MethotrexateapprovedPhase 4, Phase 3, Phase 214441959-05-2, 59-05-2126941
Synonyms:
4-amino-10-methylfolic acid
4-amino-N(10)-Methylpteroylglutamic acid
Abitrexate
Amethopterin
Amethopterine
Antifolan
Arbitrexate
Emtexate
Folex
HDMTX
L-Amethopterin
Ledertrexate
MTX
Metatrexan
Methopterin
Methotextrate
 
Methotrate
Methotrexat
Methotrexate
Methotrexate Sodium
Methotrexatum
Methylaminopterin
Methylaminopterinum
Metoject
Metotrexato
Mexate
Méthotrexate
N-Bismethylpteroylglutamic Acid
N-[4-[[(2,4-Diamino-6-pteridinyl)methyl]methylamino]benzoyl]-L-glutamic acid
Otrexup
Rasuvo
Rheumatrex
Rheumatrex Dose Pack
Trexall
3
BudesonideapprovedPhase 438151333-22-363006, 5281004
Synonyms:
(11-beta,16-alpha)-16,17-(Butylidenebis(oxy))-11,21-dihydroxypregna-1,4-diene-3,20-dione
(11beta,16alpha)-16,17-(Butylidenebis(oxy))-11,21-dihydroxypregna-1,4-diene-3,20-dione
(4aR,4bS,5S,6aS,6bS,8R,9aR,10aS,10bS)-5-hydroxy-6b-(hydroxyacetyl)-4a,6a-dimethyl-8-propyl-4a,4b,5,6,6a,6b,9a,10,10a,10b,11,12-dodecahydro-2H-naphtho[2',1':4,5]indeno[1,2-d][1,3]dioxol-2-one
(4aR,4bS,5S,6aS,6bS,9aR,10aS,10bS)-5-hydroxy-6b-(hydroxyacetyl)-4a,6a-dimethyl-8-propyl-4a,4b,5,6,6a,6b,9a,10,10a,10b,11,12-dodecahydro-2H-naphtho[2',1':4,5]indeno[1,2-d][1,3]dioxol-2-one
(R,S)-11b,16a,17,21,tetrahydroxypregna-1,4-diene-3,20-dione cyclic 16,17-acetal with buty raldehyde
(RS)-(11beta,16alpha)-16,17-[Butylidenebis(oxy)]-11,21-dihydroxypregna-1,4-diene-3,20-dione
(RS)-11beta,16alpha,17,21-Tetrahydroxypregna-1,4-diene-3,20-dione cyclic 16,17-acetal with butyraldehyde
(S)-16alpha,17-(Butylidenedioxy)-11beta,21-dihydroxypregna-1,4-diene-3,20-dione
11beta,21-dihydroxy-16alpha,17alpha-(butane-1,1-diyldioxy)pregna-1,4-diene-3,20-dione
16,17-Butylidenebis(oxy)-11,21-dihydroxypregna-1,4-diene-3,20-dione
16,17-Butylidenebis(oxy)-11-,21-dihydroxypregna-1,4-diene-3,20-dione
16-alpha,17-alpha-Butylidenedioxy-11-beta,21-dihydroxy-1,4-pregnadiene-3,20-dione
16alpha(R),17-(Butylidenebis(oxy))-11beta,21-dihydroxypregna-1,4-diene-3,20-dione
16alpha-,17alpha--butylidenedioxypregna-1,4-diene-11beta-,21-diol-3,20-dione
51333-22-3
AC-4697
AC1L1DQE
AC1L1Y6Y
AC1L22VC
AC1MHWI7
B 7777
B7777_SIGMA
BPBio1_000523
BRD-A34299591-001-03-4
BRD-A82238138-001-01-7
BSPBio_000475
BSPBio_002160
Bidien
Bio-0010
Budecort Inhaler
Budenofalk
Budeson
Budesonide
Budesonide (JAN/USAN/INN)
Budesonide Easyhaler
Budesonide Inhalation
Budesonide MMX
Budesonide Nasal
Budesonide [USAN:INN:BAN:JAN]
Budesonido
Budesonido [INN-Spanish]
Budesonidum
Budesonidum [INN-Latin]
Budiair
Budicort
C25H34O6
CCRIS 5230
CHEBI:3207
CHEBI:656601
CHEMBL1370
CID2462
CID3033890
CID40000
CID5281004
CID63006
CPD000058337
Cortivent
D00246
DB01222
Desowen
Dexbudesonide
Dexbudesonide [INN]
DivK1c_000475
EINECS 257-139-7
EINECS 257-160-1
EINECS 257-161-7
EU-0100174
Entocort
Entocort EC
Entocort EC (TN)
Giona Easyhaler
HMS1569H17
HMS1921I22
HMS2094I13
HMS501H17
 
Horacort
IDI1_000475
Inflammide
KBio1_000475
KBio3_001660
KBioGR_001361
LS-187734
LS-7235
Lopac0_000174
MAP-0010
MLS000028507
MLS001077323
MLS002207112
Micronyl
Miflonide
MolPort-002-529-265
MolPort-003-666-332
MolPort-003-986-909
NCGC00015165-03
NCGC00021318-03
NCGC00021318-06
NCGC00089747-02
NCGC00089747-03
NCGC00089747-04
NCGC00178789-01
NINDS_000475
Noex
Preferid
Pregna-1,4-diene-3,20-dione, 16,17-butylidenebis(oxy)-11,21-dihydroxy-, (11beta,16alpha(R))-, and 16alpha,17-((S)-Butylidenebis(oxy))-11beta,21-dihydroxypregna-1,4-diene-3,20-dione
Prestwick0_000518
Prestwick1_000518
Prestwick2_000518
Prestwick3_000518
Prestwick_840
Pulmaxan
Pulmaxan turbohaler
Pulmicort
Pulmicort (TN)
Pulmicort FLEXHALER
Pulmicort Flexhaler
Pulmicort Nebuamp
Pulmicort Respules
Pulmicort Topinasal
Pulmicort Turbuhaler
Pulmicort turbuhaler
Respules
Rhinocort
Rhinocort Aqua
Rhinocort Turbuhaler
Rhinocort alpha
Rhinocort, Pulmicort , Entocort, Symbicort, Noex. Entocort EC, Budesonide
Rhinosol
S 1320
S-1320
S1286_Selleck
SAM002699898
SMR000058337
SPBio_000586
SPBio_002396
SPECTRUM1500813
ST51039033
Spectrum2_000623
Spectrum3_000620
Spectrum4_000821
Spectrum5_001738
Spirocort
TL8003397
Tridesilon
UDB
UNII-168L5HT37P
UNII-2HI1006KPH
UNII-Q3OKS62Q6X
Uceris
Unit dose budesonide
ZINC03938751
ZINC04097286
budesonide
4
Pregabalinapproved, illicit, investigationalPhase 4, Phase 3, Phase 2340148553-50-85486971
Synonyms:
(3S)-3-(aminomethyl)-5-methylhexanoic acid
(R-)-3-isobutyl GABA
(S)-3-(Aminomethyl)-5-methylhexanoic acid
(S)-3-Isobutyl gaba
(S+)-3-isobutyl GABA
121GE001
148553-50-8
3-Isobutyl gaba
3-isobutyl GABA
AC-1158
AC1NUP03
AKOS005145504
C080245
C8H17NO2
CHEBI:236161
CHEMBL1059
CI 1008
CI-1008
CID5486971
 
D02716
DB00230
FT-0080911
HSDB 7530
LS-75191
Lyrica
Lyrica (TN)
MolPort-000-861-733
PD 144723
PD-144723
Pregabalin
Pregabalin (JAN/USAN/INN)
Pregabalin [USAN]
Pregablin
S-(+)-3-isobutylgaba
S1731_Selleck
SBB062901
TL8001062
TOS-BB-0910
UNII-55JG375S6M
5
Natalizumabapproved, investigationalPhase 493189261-10-7
Synonyms:
189261-10-7
Anti-VLA4
Anti-alpha4 integrin
 
D06886
Natalizumab
Natalizumab (INN)
Tysabri
Tysabri (TN)
6
AdalimumabapprovedPhase 4443331731-18-116219006
Synonyms:
331731-18-1
Adalimumab
Adalimumab (USAN/INN)
Adalimumab (genetical recombination)
 
Adalimumab (genetical recombination) (JAN)
D02597
Humira
Humira (TN)
Humira Pen
Ig gamma-1 chain C region
7
Etoricoxibapproved, investigationalPhase 489202409-33-4123619
Synonyms:
202409-33-4
5-Chloro-3-(4-methanesulfonyl-phenyl)-6'-methyl-[2,3']bipyridinyl
5-Chloro-6'-methyl-3-(p-(methylsulfonyl)phenyl)-2,3'-bipyridine
5-chloro-2-(6-Methylpyridin-3-yl)-3-(4-(methylsulfonyl)phenyl)pyridine
5-chloro-2-(6-methylpyridin-3-yl)-3-(4-methylsulfonylphenyl)pyridine
5-chloro-6'-Methyl-3-(P-(methylsulfonyl)phenyl)-2,3'-bipyridine
5-chloro-6'-methyl-3-[4-(methylsulfonyl)phenyl]-2,3'-bipyridine
5CH
AC1L3WZM
Algix
Arcoxia
C11718
C422649
CHEBI:106706
CHEBI:6339
CHEMBL416146
CID123619
D03710
DB01628
DB07166
ETORICOXIB
 
Etoricoxib
Etoricoxib (USAN/INN)
Etoricoxib [USAN:INN:BAN]
Etoricoxibe
Etoricoxibum
FT-0082494
HMS2090A05
L-791456
L001141
L791456
LS-181802
MK 0663
MK 663
MK-0663
MK-663
Merck Sharp & Dohme brand of etoricoxib
MolPort-003-847-339
NCGC00164578-01
Nucoxia
Tauxib
UNII-WRX4NFY03R
ZINC00579472
8
PrednisoloneapprovedPhase 4108250-24-85755
Synonyms:
(11beta)-11,17,21-Trihydroxypregna-1,4-diene-3,20-dione
.DELTA.1-Cortisol
.DELTA.1-Dehydrocortisol
.DELTA.1-Dehydrohydrocortisone
.DELTA.1-Hydrocortisone
.delta.-Cortef
.delta.-Stab
1,2-Dehydrohydrocortisone
1,4-Pregnadiene-11beta,17alpha,21-triol-3,20-dione
1,4-Pregnadiene-3,20-dione-11beta,17alpha,21-triol
1-Dehydrocortisol
1-Dehydrohydrocortisone
3,20-dioxo-11beta,17alpha,21-Trihydroxy-1,4-pregnadiene
46656_FLUKA
46656_RIEDEL
50-24-8
58201-11-9
8056-11-9
AC-1773
AC1L1L2E
Ak-Pred
Ak-Tate
Alphadrol
Articulose-50
BPBio1_000164
BRD-K98039984-001-03-0
BRN 1354103
BSPBio_000148
Bio-0666
Bubbli-Pred
C07369
CCRIS 980
CHEBI:8378
CHEMBL131
CID5755
CO-Hydeltra
CPD000718761
Co-Hydeltra
Codelcortone
Cordrol
Cortalone
Cotogesic
Cotolone
D00472
D011239
DB00860
Decaprednil
Decortin H
Delcortol
Delta F
Delta(1)-dehydrohydrocortisone
Delta-Cortef
Delta-Cortef (TN)
Delta-Ef-Cortelan
Delta-Stab
Delta-stab
Deltacortenol
Deltacortril
Deltacortril Enteric
Deltahydrocortisone
Deltasolone
Deltisilone
Depo-Medrol
Derpo PD
Derpo Pd
Dexa-Cortidelt Hostacortin H
Dexa-Cortidelt hostacortin H
Di Adreson F
Di-Adreson F
Di-Adreson-F
Di-adreson F
DiAdresonF
Dicortol
Donisolone
Dydeltrone
EINECS 200-021-7
Eazolin D
Econopred
Econopred Plus
Erbacort
Erbasona
Estilsona
Fernisolone
Fernisolone P
Fernisolone-P
Flamasone
Flo-pred
HMS1568H10
HMS2090J05
HSDB 3385
Hostacortin H
Hydeltra
Hydeltra-Tba
Hydeltrasol
Hydeltrone
Hydrodeltalone
Hydrodeltisone
Hydroretrocortin
Hydroretrocortine
I-Pred
Inflamase Forte
Inflamase Mild
K 1557
Key-Pred
Klismacort
LMST02030179
LS-7669
Lentosone
Lite Pred
M-Predrol
MLS001304083
 
MLS002154250
MLS002207037
Medrol
Medrol Acetate
Metacortandralone
Methylprednisolone Acetate
Meti-Derm
Meticortelone
Metreton
Millipred
MolPort-002-507-147
NCGC00179649-01
NSC 9120
NSC9120
NSC9900
Neo-Delta-Cortef
Nisolone
Nor-Pred T.B.A.
Ocu-Pred
Ocu-Pred Forte
Omnipred
Ophtho-Tate
Orapred
P0152_SIGMA
P0637
P6004_SIGMA
PRDL
PRED-G
Panafcortelone
Paracortol
Paracotol
Pediapred
Poly-Pred
Precortalon
Precortancyl
Precortilon
Precortisyl
Pred Forte
Pred Mild
Predair
Predair A
Predair Forte
Predalone 50
Predalone T.B.A.
Predate
Predate Tba
Predate-50
Predcor-25
Predcor-50
Predcor-Tba
Predisolone Sodium Phosphate
Predne-Dome
Prednelan
Predni-Dome
Prednicen
Predniliderm
Predniretard
Prednis
Prednisolona
Prednisolona [INN-Spanish]
Prednisolone
Prednisolone (JP15/USP/INN)
Prednisolone (anhydrous)
Prednisolone Acetate
Prednisolone Sodium Phosphate
Prednisolone Tebutate
Prednisolone [INN:BAN:JAN]
Prednisolonum
Prednisolonum [INN-Latin]
Predonin
Predonine
Prelone
Prenolone
Prestwick0_000274
Prestwick1_000274
Prestwick2_000274
Prestwick3_000274
Prestwick_404
Rolisone
S1737_Selleck
SAM002264639
SMR000718761
SPBio_002367
Scherisolon
Solone
Steran
Sterane
Sterolone
Supercortisol
UNII-9PHQ9Y1OLM
Ulacort
Ultra Pred
Ultracorten H
Ultracortene H
Ultracortene-H
Ultracortene-Hydrogen
Ultracortene-hydrogen
ZINC03833821
component of Ataraxoid
component of K-Predne-Dome
delta(1)-Cortisol
delta(1)-Dehydrocortisol
delta(1)-Dehydrohydrocortisone
delta(1)-Hydrocortisone
delta(sup 1)-Cortisol
delta(sup 1)-Dehydrocortisol
delta(sup 1)-Dehydrohydrocortisone
delta(sup 1)-Hydrocortisone
delta-dehydrocortisol
delta-dehydrohydrocortisone
delta-hydrocortisone
prednisolone
9
KetorolacapprovedPhase 427866635-83-43826
Synonyms:
(+-)-5-Benzoyl-2,3-dihydro-1H-pyrrolizine-1-carboxylic acid
(+-)-Ketorolac
(+-)-isomer
(.+/-.)-2,3-Dihydro-5-benzoyl-1H-pyrrolizine-1-carboxylic acid
1H-Pyrrolizine-1-carboxylic acid, 5-benzoyl-2,3-dihydro
5-(phenylcarbonyl)-2,3-dihydro-1H-pyrrolizine-1-carboxylic acid
5-Benzoyl-1,2-dihydro-3H-pyrrolo(1,2a)pyrrole-1-carboxylic acid
5-Benzoyl-2,3-dihydro-1H-pyrrolizine-1-carboxylic acid
66635-83-4
74103-06-3
AB00053682
AC-545
AC1L1GSW
Acular
Acuvail
BRD-A40639672-234-05-7
C07062
CHEBI:105080
CHEMBL469
CID3826
D020910
D08104
DB00465
 
I14-2832
Ketoralac
Ketorolac
Ketorolac (INN)
Ketorolac Tromethamine
Ketorolac [INN:BAN]
Ketorolaco
Ketorolaco [Spanish]
Ketorolacum
Ketorolacum [Latin]
Kétorolac
LS-139094
Macril
MolPort-005-933-093
NCGC00185990-01
RS 37619
RS-37619
SBB067312
STL018674
Sprix
Toradol (TN)
UNII-YZI5105V0L
ketorolac
rac-Ketorolac
10
NepafenacapprovedPhase 43978281-72-8151075
Synonyms:
2-amino-3-Benzoylbenzeneacetamide
AHR 9434
AHR-9434
AL 6515
 
AL-6515
Amfenac amide
Ilevro
Nepafenaco
Nepafenacum
Nevanac
11
MethylprednisoloneapprovedPhase 4108283-43-26741
Synonyms:
(6S,8S,9S,10R,11S,13S,14S,17R)-11,17-dihydroxy-17-(2-hydroxyacetyl)-6,10,13-trimethyl-7,8,9,11,12,14,15,16-octahydro-6H-cyclopenta[a]phenanthren-3-one
(6a,11b)-11,17,21-Trihydroxy-6-methylpregna-1,4-diene-3,20-dione
(6alpha,11beta)-11,17,21-Trihydroxy-6-methylpregna-1,4-diene-3,20-dione
(6α,11β)-11,17,21-trihydroxy-6-methylpregna-1,4-diene-3,20-dione
.DELTA.1-6.alpha.-Methylhydrocortisone
1-Dehydro-6alpha-methylhydrocortisone
1-dehydro-6alpha-Methylhydrocortisone
1-dehydro-6α-methylhydrocortisone
11-beta,17,21-Trihydroxy-6-alpha-methylpregna-1,4-diene-3,20-dione
11beta,17,21-Trihydroxy-6alpha-methylpregna-1,4-diene-3,20-dione
11beta,17alpha,21-Trihydroxy-6alpha-methyl-1,4-pregnadiene-3,20-dione
11beta,17alpha,21-Trihydroxy-6alpha-methylpregna-1,4-diene-3,20-dione
121673-01-6
4-08-00-03498 (Beilstein Handbook Reference)
46436_FLUKA
46436_RIEDEL
570-35-4
6 Methylprednisolone
6-Methylprednisolone
6-alpha-Methylprednisolone
6.alpha.-Methylprednisolone
6923-42-8
6alpha-Methyl-11beta,17alpha,21-trihydroxy-1,4-pregnadiene-3,20-dione
6alpha-Methyl-11beta,17alpha,21-triol-1,4-pregnadiene-3,20-dione
6alpha-Methylprednisolone
6alpha-methyl-11beta,17alpha,21-triol-1,4-pregnadiene-3,20-dione
83-43-2
A-methapred
AC1L1N7A
Artisone-Wyeth
Artisone-wyeth
BPBio1_000174
BRD-K35240538-001-03-1
BRN 2340300
BSPBio_000158
Besonia
Bio-0658
CHEBI:6888
CHEMBL650
CID6741
CPD000058330
D00407
D008775
DB00959
Depo-Medrol (acetate)
Depo-medrol
Dopomedrol
EINECS 201-476-4
Esametone
Firmacort
HMS1568H20
HMS2090B13
HSDB 3127
LMST02030178
LS-118498
Lemod
M0639_SIGMA
M1665
MEPRDL
MLS000028541
MLS001148159
MLS002207191
Medesone
Medixon
Medlone 21
 
Medrate
Medrol
Medrol (TN)
Medrol Adt Pak
Medrol Dosepak
Medrol adt pak
Medrol dosepak
Medrol, Solu-Medrol, Medrone, Methylprednisolone
Medrone
Mesopren
Metastab
Methyleneprednisolone
Methylprednisolon
Methylprednisolone
Methylprednisolone (JP15/USP/INN)
Methylprednisolone [USAN:INN:BAN:JAN]
Methylprednisolone, 6-alpha
Methylprednisolonum
Methylprednisolonum [INN-Latin]
Metilbetasone
Metilprednisolona
Metilprednisolona [INN-Spanish]
Metilprednisolone
Metilprednisolone [DCIT]
Metilprednisolone [Dcit]
Metipred
Metrisone
Metrocort
Metysolon
Moderin
MolPort-002-528-554
NCGC00022735-03
NCI60_001657
NSC-19987
NSC19987
Nirypan
Noretona
Predni N Tablinen
Prednol- L
Pregna-1,4-diene-3,20-dione, 11beta,17,21-trihydroxy-6alpha-methyl- (8CI)
Prestwick0_000279
Prestwick1_000279
Prestwick2_000279
Prestwick3_000279
Prestwick_622
Promacortine
Reactenol
S1733_Selleck
SAM002589984
SMR000058330
SPBio_002377
Sieropresol
Solomet
Solu-medrol
Summicort
Suprametil
U 7532
UNII-X4W7ZR7023
Urbason
Urbasone
Wyacort
ZINC03875560
delta(1)-6alpha-Methylhydrocortisone
delta(sup 1)-6-alpha-Methylhydrocortisone
methylprednisolone
methylprenisolone
12
FoscarnetapprovedPhase 43063585-09-13415
Synonyms:
1nki
34156-56-4
4428-95-9
4428-95-9 (Parent)
63585-09-1
63585-09-1 (tri-hydrochloride salt)
79510_FLUKA
A 29622
A-29622
AC-2085
AC1L1FVT
AC1L2C37
AC1L5400
AC1NB82R
AC1Q1UNV
AR-1L5079
Ambap63585-09-1
BSPBio_003067
C06456
CHEBI:127780
CHEBI:141644
CHEBI:60269
CHEMBL666
CHEMBL754
CID169569
CID3415
CID44561
Carboxyphosphonic acid
D00579
D02267
DB00529
DRG-0017
Dihydroxyphosphinecarboxylic acid oxide
Dihydroxyphosphinecarboxylic acid oxide and MSL, neutralizing monoclonal antibody
Dihydroxyphosphinecarboxylic acid oxide trisodium salt
Dihydroxyphosphinecarboxylic acid oxide trisodium salt hexahydrate
DivK1c_000915
EHB 776
EHB-776
FOSCARNET SODIUM
Formic acid, phosphono-, trisodium salt, hexahydrate
Forscarnet sodium
Foscarmet
Foscarnet
Foscarnet & IFN-.ALPHA.
Foscarnet Sodium
Foscarnet sodico
Foscarnet sodico [Spanish]
Foscarnet sodique
Foscarnet sodique [French]
Foscarnet sodique [INN-French]
Foscarnet sodium
Foscarnet sodium (USAN/INN)
Foscarnet sodium [USAN:INN:BAN]
Foscarnet sodium hydrate
Foscarnet sodium hydrate (JAN)
Foscarneto sodico
Foscarneto sodico [INN-Spanish]
Foscarnetum natricum
Foscarnetum natricum [INN-Latin]
Foscarnetum natricum [Latin]
Foscavir
Foscavir (TN)
HMS1921D18
HMS2092N15
 
HMS502N17
HS-0008
IDI1_000915
KBio1_000915
KBio2_001839
KBio2_004407
KBio2_006975
KBio3_002567
KBioGR_001419
KBioSS_001839
LS-105952
LS-105953
LS-183979
LS-187063
LS-187793
MSL & PFA
MolPort-003-665-560
MolPort-003-895-968
NCGC00094941-01
NCGC00094941-02
NChemBio.2007.9-comp7
NINDS_000915
NSC313410
P6801_ALDRICH
P6801_SIGMA
PFA & rIFN.alpha.A
Phgosphonocarboxylic acid
Phosphinecarboxylic acid, dihydroxy-, oxide
Phosphinecarboxylic acid, dihydroxy-, oxide, trisodium salt
Phosphinecarboxylic acid, dihydroxy-, oxide, trisodium salt, hexahydrate
Phosphonoformate
Phosphonoformate(trisodium) & Recombinant Alpha-A Interferon
Phosphonoformic acid
Phosphonoformic acid & IFN-.ALPHA.
Phosphonoformic acid trisodium salt hexahydrate
Phosphonoformic acid, trisodium salt
Phosphonoformic acid, trisodium salt, hexahydrate
Phosphonomethanoic acid
Prestwick_1024
SPBio_000735
SPECTRUM1502019
Sodium phosphonoformate tribasic hexahydrate
Spectrum2_000668
Spectrum3_001484
Spectrum4_000840
Spectrum5_000932
Spectrum_001359
Triapten
Trisodium carboxyphosphate
Trisodium phosphonoformate
Trisodium phosphonoformate hexahydrate
Trisodium phosphonoformte hexahydrate
UNII-364P9RVW4X
UNII-964YS0OOG1
Virudin
dihydroxyphosphanecarboxylic acid oxide
foscarnet
foscarnet sodium hexahydrate
phosphonomethanoic acid
sodium dioxidophosphanecarboxylate oxide hydrate(3:1:6)
trisodium carboxyphosphate (anhydrous)
trisodium dioxidophosphanecarboxylate oxide
trisodium dioxidophosphinecarboxylate oxide
trisodium phosphonatoformate
trisodium phosphonatoformate hexahydrate
trisodium phosphonoformate (anhydrous)
13
Folic Acidapproved, nutraceuticalPhase 4, Phase 3, Phase 2292459-30-36037
Synonyms:
(2S)-2-[[4-[(2-amino-4-oxo-1H-pteridin-6-yl)methylamino]benzoyl]amino]pentanedioic acid
01769_FLUKA
2d0k
33609-88-0
36653-55-1 (mono-potassium salt)
59-30-3
6484-89-5 (mono-hydrochloride salt)
AC-11682
AC1L1LNX
AI3-26387
AKOS000503224
ARONIS014410
Acfol (Spain)
Acide folique
Acide folique [INN-French]
Acido folico
Acido folico [INN-Spanish]
Acidum folicum
Acidum folicum [INN-Latin]
Acifolic
Antianemia factor
Apo-Folic
BIDD:ER0563
BIDD:GT0641
BIF0608
BPBio1_000654
BSPBio_000594
BSPBio_002338
C00504
C20H20N6O6
CAS-59-30-3
CCRIS 666
CHEBI:27470
CHEMBL1622
CID6037
CPD000471860
Cytofol
D00070
DB00158
DivK1c_000494
Dosfolat B activ
EINECS 200-419-0
F0043
F7876_SIAL
F7876_SIGMA
F8758_SIGMA
F8798_SIAL
F8890_SIGMA
FOL
Facid
Factor U
Folacid
Folacin
Folaemin
Folaemin [Netherlands]
Folan
Folasic (Australia)
Folate
Folbal
Folcidin
Folcidin (VAN)
Folcysteine
Foldine
Foldine [France]
Folettes
Foliamin
Folic
Folic Acid
Folic acid
Folic acid (JP15/USP/INN)
Folic acid (TN)
Folic acid [BAN:INN:JAN]
Folic acid [INN:BAN:JAN]
Folic acid dihydrate
Folicet
Folicet (TN)
Folico
Folico (Italy)
Folina
Folina (Italy)
Folipac
 
Folsaeure
Folsan
Folsaure
Folsav
Folvite
Folvron
Glutamic acid, N-(p-(((2-amino-4-hydroxypyrimido(4,5-b)pyrazin-6-yl)methyl)amino)benzoyl)-, L
HMS1921D20
HMS2092N17
HMS501I16
HSDB 2002
IDI1_000494
InChI=1/C19H19N7O6/c20-19-25-15-14(17(30)26-19)23-11(8-22-15)7-21-10-3-1-9(2-4-10)16(29)24-12(18(31)32)5-6-13(27)28/h1-4,8,12,21H,5-7H2,(H,24,29)(H,27,28)(H,31,32)(H3,20,22,25,26,30)/t12-/m0/s
Incafolic
KBio1_000494
KBio2_001861
KBio2_004429
KBio2_006997
KBio3_001558
KBioGR_002222
KBioSS_001861
Kyselina listova
Kyselina listova [Czech]
LS-2157
Liver Lactobacillus casei factor
MLS001304016
MLS001335861
Millafol
Mission prenatal
Mittafol
MolPort-004-285-551
N-(4-(((2-Amino-1,4-dihydro-4-oxo-6-pteridinyl)methyl)amino)benzo- yl)-L-glutamic acid
N-(4-((2-Amino-1,4-dihydro-4-oxo-6-pteridinyl)methyl)amino)benzoyl)-L-glutamic acid
N-(4-{[(2-Amino-4-oxo-3,4-dihydropteridin-6-yl)methyl]amino}benzoyl)-L-glutamic acid
N-(4-{[(2-amino-4-oxo-1,4-dihydropteridin-6-yl)methyl]amino}benzoyl)-L-glutamic acid
N-(p-(((2-Amino-4-hydroxy-6-pteridinyl)methyl)amino)benzoyl)-L-glutamic acid
N-Pteroyl-L-glutamic acid
N-[(4-{[(2-Amino-4-oxo-1,4-dihydropteridin-6-yl)methyl]amino}phenyl)carbonyl]-L-glutamic acid
N-[(4-{[(2-amino-4-oxo-1,4-dihydropteridin-6-yl)methyl]amino}phenyl)carbonyl]-L-glutamic acid
N-[4-[[(2-Amino-3,4-dihydro-4-oxo-6-pteridinyl)methyl]amino]benzoyl]-L-glutamic acid
NCGC00016265-01
NCGC00142391-01
NINDS_000494
NSC 3073
Nifolin
Nifolin [Denmark]
Novofolacid
Novofolacid [Canada]
PGA
PGA (VAN)
Prestwick3_000627
Prestwick_230
PteGlu
Pteroyl-L-glutamate
Pteroyl-L-glutamic acid
Pteroyl-L-monoglutamate
Pteroyl-L-monoglutamic acid
Pteroylglutamate
Pteroylglutamic acid
Pteroylmonoglutamate
Pteroylmonoglutamic acid
SAM002264616
SDCCGMLS-0066738.P001
SMP2_000137
SMR000471860
SPBio_001357
SPECTRUM1502020
Serum Folate Level
Spectrum2_001459
Spectrum3_000749
Spectrum4_001751
Spectrum5_000602
Spectrum_001381
UNII-935E97BOY8
Usaf cb-13
Vitamin B11
Vitamin B9
Vitamin Bc
Vitamin Be
Vitamin M
bmse000299
folic acid
nchembio.108-comp10
14
Phosphonoacetic AcidexperimentalPhase 4304408-78-0546
Synonyms:
Carboxymethanephosphonate
Carboxymethanephosphonic acid
Disodium carboxymethylphosphonate
Disodium phosphonoacetate
Disodium phosphonoacetate monohydrate
Fosfonet
Fosfonet sodium
 
Fosfonoacetate
Fosfonoacetic acid
Lopac-P-6909
PAE
PPA
Phosphonacetate
Phosphonacetic acid
Phosphonoacetate
Phosphonoacetic acid
15AntibodiesPhase 4, Phase 2, Phase 3, Phase 14477
16VaccinesPhase 4, Phase 3, Phase 2, Phase 16085
17ImmunoglobulinsPhase 4, Phase 2, Phase 3, Phase 14477
18Immunologic FactorsPhase 4, Phase 3, Phase 2, Phase 118483
19Anti-Asthmatic AgentsPhase 4, Phase 3, Phase 22796
20Analgesics, Non-NarcoticPhase 4, Phase 2, Phase 35184
21Vitamin B ComplexPhase 4, Phase 3, Phase 22847
22Protein Kinase InhibitorsPhase 4, Phase 3, Phase 23162
23Anti-Inflammatory AgentsPhase 4, Phase 2, Phase 18478
24Bronchodilator AgentsPhase 4, Phase 3, Phase 22377
25Folic Acid AntagonistsPhase 4, Phase 3, Phase 21643
26Immunosuppressive AgentsPhase 4, Phase 3, Phase 2, Phase 110422
27Nucleic Acid Synthesis InhibitorsPhase 4, Phase 3, Phase 23836
28Antineoplastic Agents, HormonalPhase 4, Phase 3, Phase 2, Phase 14256
29Anti-Retroviral AgentsPhase 4, Phase 3, Phase 2, Phase 12794
30AntipruriticsPhase 4, Phase 2, Phase 3619
31
CapsaicinPhase 4, Phase 2, Phase 3144404-86-41548943
Synonyms:
(6E)-N-(4-hydroxy-3-methoxybenzyl)-8-methylnon-6-enamide
(6E)-N-{[4-hydroxy-3-(methyloxy)phenyl]methyl}-8-methylnon-6-enamide
(E)-8-Methyl-N-vanillyl-6-nonenamide
(E)-8-Methyl-N-vanillyl-6-nonenamide(8cl)
(E)-Capsaicin
(E)-N-((4-Hydroxy-3-methoxyphenyl)-methyl)-8-methyl-6-nonenamide
(E)-N-[(4-hydroxy-3-methoxyphenyl)methyl]-8-methylnon-6-enamide
(E)8-methyl-N-vanillyl-6-Nonenamide
12084_FLUKA
21748_FLUKA
21748_SIGMA
21750_FLUKA
21750_SIGMA
360376_ALDRICH
360376_SIGMA
404-86-4
6-Nonenamide, (E)-N-((4-hydroxy-3-methoxy-phenyl)methyl)-8-methyl
6-Nonenamide, 8-methyl-N-vanillyl-, (E)- (8CI)
8 Methyl N Vanillyl 6 Nonenamide
8-Methyl-N-Vanillyl-6-Nonenamide
8-Methyl-N-vanillyl-trans-6-nonenamide
912457-62-6
AC1LU7K3
AC1Q46B3
Alacan Brand of Capsaicin
Antiphlogistine Rub A-535 Capsaicin
Axsain
BPBio1_001053
BRD-K37056290-001-01-1
BRD-K50590187-001-06-6
BRN 2816484
BSPBio_000957
BSPBio_001548
BSPBio_002917
Bio-0615
C-1700
C06866
C18H27NO3
CAPSAICIN (2444-46-4 NONIVAMIDE (SYNTHETIC CAPSAICIN))
CAPSAICINE
CCRIS 1588
CHEBI:3374
CHEMBL294199
CID1548943
Capsaicin
Capsaicin (JAN/USP)
Capsaicin (Natural)
Capsaicin (in oleoresin of capsicum)
Capsaicin (jan/usp)
Capsaicin Patch
Capsaicin [USAN]
Capsaicin [in oleoresin of capsicum]
Capsaicin [usan]
Capsicum Farmaya
Capsidol
Capsin
Capzasin
Carter Horner Brand of Capsaicin
Caswell No. 158
Centrum Brand of Capsaicin
D002211
D00250
E-CAPSAICIN
E-Capsaicin
EINECS 206-969-8
EPA Pesticide Chemical Code 070701
Elan Brand of Capsaicin
FEMA No. 3404
FT-0082538
Flemming Brand of Capsaicin
Gelcen
HMS1361N10
HMS1570P19
HMS1791N10
HMS1921H11
HMS1989N10
 
HMS2089N11
HMS2092D21
HMS501B16
HSDB 954
I01-2469
IDI1_000354
IDI1_034018
Isodecenoate
Isodecenoic acid
Isodecenoic acid vanillylamide
Katrum
LS-2138
Link Brand of Capsaicin
M1149
M2028_SIGMA
MEGxp0_001448
MLS002154049
MR3H3
Medicis Brand of Capsaicin
MolPort-001-742-263
N-(4-Hydroxy-3-methoxybenzyl)-8-methylnon-trans-6-enamide
N-(4-hydroxy-3-methoxybenzyl)-8-methylnon-6-enamide
N-[(4-Hydroxy-3-methoxyphenyl)methyl]-8-methyl-6-nonenamide
N-[(4-hydroxy-3-methoxy-phenyl)methyl]nonanamide
NCGC00090853-01
NCGC00090853-02
NCGC00090853-03
NCGC00090853-04
NCGC00090853-06
NCGC00090853-07
NCGC00090853-08
NCGC00090853-09
NCI-C56564
NGX 4010
NGX-1998
NGX-3781
NGX-4010
NGX-7325
NGX4010
NSC 56353
NSC56353
Prestwick2_000879
Prestwick3_000879
Prestwick_204
Qutenza
S1990_Selleck
SDCCGMLS-0066678.P001
SMP2_000337
SMR000718774
SPECTRUM1501128
Smaller Brand of Capsaicin
Spectrum5_000538
Styptysat
TL8002946
TQ-1018
Thompson Brand of Capsaicin
Transacin
UNII-S07O44R1ZM
UPCMLD-DP092
UPCMLD-DP092:001
UPCMLD-DP092:002
Vinas Brand of Capsaicin
ZINC01530575
ZOSTRIX (TN)
Zacin
Zostrix
Zostrix (TN)
Zostrix HP
[(E)-N-(4-Hydroxy-3-methoxyphenyl)methyl]-8-methyl-6-nonenamide
depletes Substance P
epsilon-Capsaicin
n-(4-hydroxy-3-methoxybenzyl)-8-methyl-6-nonenamide
nchembio.146-comp1
nchembio862-comp2
neurotoxic
trans-8-Methyl-N-vanillyl-6-nonenamide
trans-Capsaicin
32HormonesPhase 4, Phase 3, Phase 111748
33Protective AgentsPhase 4, Phase 35651
34Antiviral AgentsPhase 4, Phase 3, Phase 2, Phase 18071
35Dermatologic AgentsPhase 4, Phase 2, Phase 34555
36Gastrointestinal AgentsPhase 4, Phase 3, Phase 16401
37Phase 4
38valacyclovirPhase 4, Phase 3, Phase 2, Phase 1101
39AntiemeticsPhase 4, Phase 13213
40Anti-Infective AgentsPhase 4, Phase 3, Phase 2, Phase 117220
41Hormones, Hormone Substitutes, and Hormone AntagonistsPhase 4, Phase 3, Phase 19988
42AnalgesicsPhase 4, Phase 2, Phase 39358
43AnticonvulsantsPhase 4, Phase 3, Phase 22249
44calcium channel blockersPhase 4, Phase 3, Phase 21743
45Central Nervous System DepressantsPhase 4, Phase 2, Phase 3, Phase 110016
46Calcium, DietaryPhase 4, Phase 3, Phase 2, Phase 14678
47MF59 oil emulsionPhase 496
48Pharmaceutical SolutionsPhase 4, Phase 3, Phase 1, Phase 27004
49Antirheumatic AgentsPhase 4, Phase 3, Phase 2, Phase 18496
50Peripheral Nervous System AgentsPhase 4, Phase 2, Phase 3, Phase 118510

Interventional clinical trials:

(show top 50)    (show all 396)
idNameStatusNCT IDPhase
1Immunogenicity and Safety of 2 Doses of Live Attenuated Varicella VaccineCompletedNCT02173899Phase 4
2Safety of a Second Dose of Biken's Varicella VaccineCompletedNCT00830648Phase 4
3ZOSTAVAX™ Safety and Immunogenicity in Korean Adults (V211-034)CompletedNCT01556451Phase 4
4A Study of Vacyless® Versus Valtrex® in Patients With Herpes ZosterCompletedNCT02152800Phase 4
5Immunogenicity and Safety of Live Attenuated Varicella Vaccine Combined With Live Attenuated JE VaccineCompletedNCT01815073Phase 4
6The Immunogenicity of Varicella-zoster Virus Vaccine in HIV-infected ChildrenCompletedNCT01138215Phase 4
7Safety and Immunogenicity Study of Live Attenuated Vaccine Against Varicella Without GelatinCompletedNCT01684072Phase 4
8Immunogenicity and Safety Study of 2 Doses of Live Attenuated Varicella VaccineCompletedNCT01817270Phase 4
9Varicella Vaccination With PulmicortCompletedNCT00641446Phase 4
10ZOSTAVAX™ Safety Study in Subjects ≥ 60 Years of Age (V211-020)CompletedNCT00550745Phase 4
11Concomitant Use of Hepatitis A Vaccine With Measles, Mumps, Rubella and Varicella Vaccine and Pneumococcal 7-Valent Conjugate Vaccine in Healthy 12-Month-Old Children (V251-067)CompletedNCT00312858Phase 4
12Zostavax® at Minimum Release Specification Approaching ExpiryCompletedNCT00681031Phase 4
13Immunogenicity and Safety of Combined Vaccine to Prevent Measles, Mumps, Rubella and Chickenpox DiseasesCompletedNCT00126997Phase 4
14Effective Study of Live Attenuated Varicella Vaccine to Treat Severe Resistant PsoriasisCompletedNCT01356004Phase 4
15MMR and Varicella Vaccine in Premature InfantsCompletedNCT00156559Phase 4
16Palatability Testing of a New Paediatric Formulation of ValacyclovirCompletedNCT01682109Phase 4
17Effectiveness Assessment of Vaccinating Schoolchildren Against InfluenzaCompletedNCT01693380Phase 4
18Safety Study of a Refrigerator-Stable Formulation of VARIVAX®CompletedNCT00432731Phase 4
19Study of the Influence of Vaccination in HIV Viral Load and Immunologic Responses Against HIVCompletedNCT00329251Phase 4
20MF59-adjuvanted Influenza Vaccine and 23-valent Pneumococcal Polysaccharide VaccineCompletedNCT02225327Phase 4
21Pregabalin in the Treatment of Essential TremorCompletedNCT00646451Phase 4
22Immunogenicity and Safety of PCV13 and Fluad in Adults Aged ≥60 YearsCompletedNCT02215863Phase 4
23Comparison of Slow and Fast Transition From Stimulants to Atomoxetine in Children and Adolescents With Attention Deficit/Hyperactivity Disorder(ADHD)CompletedNCT00760747Phase 4
24The Safety and Immunogenicity Research of Live Attenuated Varicella Vaccine After the 2 Doses VaccinationRecruitingNCT01866566Phase 4
25Acupuncture in Herpes Zoster Neuralgia (ACUZoster)RecruitingNCT00885586Phase 4
26Pilot Study to Describe Immune Responses of Healthy Women Following Immunization With Varicella Zoster Virus VaccineRecruitingNCT02514018Phase 4
27Persistence of Varicella Immunity in Hospital Employees Receiving Varicella VaccineRecruitingNCT02026089Phase 4
28Safety and Immunogenicity of a Zoster Vaccine in SLERecruitingNCT02477150Phase 4
29Immune Response to Shingles VaccinationRecruitingNCT02624375Phase 4
30An Efficacy And Safety Study Evaluating Tofacitinib With And Without Methotrexate Compared To Adalimumab With MethotrexateRecruitingNCT02187055Phase 4
31Difference in Efficacy of Natalizumab Versus Fingolimod for the Treatment of Multiple SclerosisRecruitingNCT01981161Phase 4
32Evaluation of the Efficacy, Tolerability and Safety of Etoricoxib (Arcoxia) in Patients With Neuropathic PainRecruitingNCT01264237Phase 4
33"Equistasi" and Gait in HemiparesisRecruitingNCT02714478Phase 4
34T Cell Responses to Varicella Zoster Virus (VZV)Active, not recruitingNCT01911065Phase 4
35Immune Persistence After Inoculated With One-dose Freeze-Dried Live Attenuated Varicella Vaccine in Children Vaccine in ChildrenActive, not recruitingNCT01982409Phase 4
36Safety and Immunogenicity of Zostavax Vaccine in Patients Undergoing Living Donor Kidney TransplantationActive, not recruitingNCT00940940Phase 4
37Effect of Anti-inflammatory Topical Prednisolone, Nepafenac and Ketorolac in Intra-operative Mydriasis in FacetectomiesActive, not recruitingNCT00865540Phase 4
38Study on Effectiveness of 2-dose Live Attenuated Varicella VaccineEnrolling by invitationNCT02146469Phase 4
39The Safety, Immunogenicity and Immune Effect Research of the Varicella Vaccine After the 2nd Dose VaccinationEnrolling by invitationNCT01830283Phase 4
40Immunodeficiency in Cartilage-hair Hypoplasia: Sub-project on Safety of Vaccination Against ChickenpoxEnrolling by invitationNCT02383797Phase 4
41Olive Oil's Cream Effectiveness in Prevention of Pressure Ulcers in Immobilized Patients in Primary CareEnrolling by invitationNCT01595347Phase 4
42Efficacy and Safety of Foscarnet Sodium and Sodium Chloride Injection in Patients With Herpes ZosterNot yet recruitingNCT02151240Phase 4
43ZOSTAVAX in Persons Imminently Receiving Chemotherapy for Solid Organ TumorsNot yet recruitingNCT02444936Phase 4
44Qutenza for Critical Ischaemia in End Stage Renal FailureNot yet recruitingNCT01704339Phase 4
45Varicella Zoster Vaccine in Patients With Plaque Psoriasis Treated With Biologic TherapySuspendedNCT02408159Phase 4
46Responses of Premature Infants to Measles-Mumps-Rubella (MMR) and Varicella VaccinesTerminatedNCT00138255Phase 4
47Study to Evaluate Efficacy, Safety and Immunogenicity of GlaxoSmithKline (GSK) Biologicals' Herpes Zoster (HZ) Vaccine GSK1437173A in Adults Aged 70 Years and OlderCompletedNCT01165229Phase 3
48Study to Evaluate Efficacy, Safety and Immunogenicity of GSK Biologicals' Herpes Zoster (HZ) Vaccine GSK1437173A in Adults Aged 50 Years and OlderCompletedNCT01165177Phase 3
49Shingles Prevention StudyCompletedNCT00007501Phase 3
50A Study of an Investigational Zoster Vaccine, in Subjects With a History of Herpes Zoster (V211-014)CompletedNCT00322231Phase 3

Search NIH Clinical Center for Herpes Zoster

Inferred drug relations via UMLS65/NDF-RT43:


Cochrane evidence based reviews: herpes zoster

Genetic Tests for Herpes Zoster

About this section

Anatomical Context for Herpes Zoster

About this section

MalaCards organs/tissues related to Herpes Zoster:

33
Skin, Eye, Kidney, Bone, Liver, T cells, Breast

FMA organs/tissues related to Herpes Zoster:

16
Nerve fiber

Animal Models for Herpes Zoster or affiliated genes

About this section

Publications for Herpes Zoster

About this section

Articles related to Herpes Zoster:

(show top 50)    (show all 1170)
idTitleAuthorsYear
1
Incidence of herpes zoster and associated events including stroke-a population-based cohort study. (26520060)
2015
2
Preauricular injection of betamethasone depot and acyclovir for the treatment of acute herpes zoster ophthalmicus. (25443191)
2015
3
Trigeminal herpes zoster complicated by Ramsay Hunt syndrome. (25607330)
2015
4
Predictors of postherpetic neuralgia in patients with herpes zoster: a pooled analysis of prospective cohort studies from North and Latin America and Asia. (25841633)
2015
5
Zosteriform Lesions in an Elderly Man-Look Beyond Herpes Zoster. (26538732)
2015
6
Elevated PD-1 expression and decreased telomerase activity in memory T cells of patients with symptomatic Herpes Zoster infection. (25399082)
2014
7
Mandibular osteonecrosis and Ramsay Hunt syndrome following a case of herpes zoster. (25234535)
2014
8
Safety and immunogenicity of an adjuvanted herpes zoster subunit candidate vaccine in HIV-infected adults: a phase I/IIa randomized, placebo-controlled study. (25371534)
2014
9
Successful differentiation of herpes zoster-associated erythema multiforme from generalized extension of herpes by rapid polymerase chain reaction analysis. (24909215)
2014
10
Acute respiratory distress syndrome due to varicella zoster virus pneumonitis in an immunocompromised patient with herpes zoster. (24330179)
2013
11
Alopecia areata associated with Herpes zoster. (23682830)
2013
12
Increased Density of Cutaneous Nerve Fibres in the Affected Dermatomes After Herpes Zoster Therapy. (23995395)
2013
13
Effects of highly active antiretroviral therapy and its adherence on herpes zoster incidence: a longitudinal cohort study. (24373482)
2013
14
Varicella zoster virus-specific immune responses to a herpes zoster vaccine in elderly recipients with major depression and the impact of antidepressant medications. (23413415)
2013
15
Safety, humoral and cell-mediated immune responses to herpes zoster vaccine in subjects with diabetes mellitus. (23603250)
2013
16
An inverse correlation of VZV skin-test reaction, but not antibody, with severity of herpes zoster skin symptoms and zoster-associated pain. (23183011)
2013
17
Multiple actinic keratoses and squamous carcinomas at the site of prior herpes zoster. (23253078)
2013
18
Cutaneous herpes zoster. (23901015)
2013
19
Effect of pharmacist intervention on herpes zoster vaccination in community pharmacies. (23636155)
2013
20
Orbital apex syndrome in herpes zoster ophthalmicus. (22830066)
2012
21
Does methotrexate increase the risk of varicella or herpes zoster infection in patients with rheumatoid arthritis? A systematic literature review. (23044005)
2012
22
Herpes zoster in patients with drug-induced hypersensitivity syndrome/DRESS. (22307980)
2012
23
Managing the care of patients with herpes zoster ophthalmicus. (21739797)
2011
24
Increased risk of a cancer diagnosis after herpes zoster ophthalmicus: a nationwide population-based study. (21232800)
2011
25
Penile herpes zoster: an unusual location for a common disease. (22218522)
2011
26
Management of herpes zoster and post-herpetic neuralgia now and in the future. (20510264)
2010
27
Epidemiology and economic burden of herpes zoster and post-herpetic neuralgia in Italy: a retrospective, population-based study. (20682044)
2010
28
Alteration in antibody-mediated immunity in patients with rituximab-combined chemotherapy and incidence of herpes zoster]. (20087040)
2010
29
Unusual formation of keloids after each episode of recurrent herpes zoster in an HIV positive patient. (21938132)
2009
30
Eruption severity and characteristics in herpes zoster ophthalmicus: correlation with visual outcome, ocular complications, and postherpetic neuralgia. (19416378)
2009
31
Disseminated herpes zoster mimicking rheumatoid vasculitis in a rheumatoid arthritis patient on etanercept. (19648728)
2009
32
Association of varicella zoster virus load in the aqueous humor with clinical manifestations of anterior uveitis in herpes zoster ophthalmicus and zoster sine herpete. (18245272)
2008
33
A vaccine to prevent herpes zoster and postherpetic neuralgia in older adults. (15930418)
2005
34
Herpes zoster and postherpetic neuralgia: prevention and management. (16190505)
2005
35
Herpes zoster ophthalmicus in an otherwise-healthy child. (16414532)
2005
36
Postherpetic neuralgia: impact of famciclovir, age, rash severity, and acute pain in herpes zoster patients. (9852980)
1998
37
Colonic pseudo-obstruction: a complication of herpes zoster. (7942751)
1994
38
Granuloma annulare arising after herpes zoster. (1399211)
1992
39
Readers comment on "Herpes zoster ophthalmicus". (1455299)
1992
40
Caring for patients with herpes zoster ophthalmicus. (2784213)
1989
41
Herpes zoster of second and third segments causing ipsilateral Horner's syndrome. (3111588)
1987
42
Herpes zoster ophthalmicus with delayed cerebral infarction and meningoencephalitis. (3311326)
1987
43
Herpes zoster ophthalmicus and delayed contralateral hemiparesis caused by cerebral angiitis: diagnosis and management approaches. (6606387)
1983
44
Herpes zoster ophthalmicus. (312096)
1979
45
Temporal artery biopsy in herpes zoster ophthalmicus with delayed arteritis. (1086062)
1976
46
PSEUDOMELANOMA OF THE IRIS AFTER HERPES ZOSTER OPHTHALMICUS. (14129246)
1964
47
Herpes zoster ophthalmicus; report of a case in a three and one-half-year-old child. (13595053)
1958
48
Successful treatment of herpes zoster ophthalmicus with antihistaminic therapy. (13294985)
1956
49
Herpes zoster with a varicelliform eruption and parotitis in chronic leukemia. (14794487)
1951
50

Variations for Herpes Zoster

About this section

Expression for genes affiliated with Herpes Zoster

About this section
Search GEO for disease gene expression data for Herpes Zoster.

Pathways for genes affiliated with Herpes Zoster

About this section

Pathways related to Herpes Zoster according to GeneCards Suite gene sharing:

(show all 28)
idSuper pathwaysScoreTop Affiliating Genes
19.7IFNG, IL2
29.7IFNG, IL2
39.7IFNG, IL2
49.6IFNG, IL10
5
Show member pathways
9.4CD8A, IFNG, IL2
69.2HLA-B, IFNA2, IFNG
7
Show member pathways
9.2IFNG, IL10, IL2
8
Show member pathways
9.2IFNG, IL10, IL2
99.2IFNG, IL10, IL2
109.2IFNG, IL10, IL2
119.2IFNG, IL10, IL2
129.1GYPC, IFNG, IL10
139.1HLA-B, IFNG, IL10
148.9CD8A, IFNG, IL10, IL2
15
Show member pathways
8.8IFNA2, IFNG, IL10, IL2
168.8IFNA2, IFNG, IL10, IL2
17
Show member pathways
8.8IFNA2, IFNG, IL10, IL2
18
Show member pathways
8.8HLA-B, IFNA2, IFNG, IL2
198.8CD8A, FCGR3A, HLA-B
20
Show member pathways
8.7CCR5, CD8A, IFNG, IL2
218.5CD8A, IFNA2, IFNG, IL10, IL2
228.5CD8A, IFNA2, IFNG, IL10, IL2
238.4FCGR3A, IFNA2, IFNG, IL10
24
Show member pathways
8.3HLA-B, IFNA2, IFNG, IL10, IL2
25
Show member pathways
8.2CCR5, CD8A, IFNG, IL10, IL2
26
Show member pathways
8.1CCR5, FCGR3A, IFNG, IL10
27
Show member pathways
8.0FCGR3A, HLA-B, IFNA2, IFNG, IL2
28
Show member pathways
8.0CD8A, HLA-B, IFNA2, IFNG, IL10, IL2

GO Terms for genes affiliated with Herpes Zoster

About this section

Biological processes related to Herpes Zoster according to GeneCards Suite gene sharing:

(show all 11)
idNameGO IDScoreTop Affiliating Genes
1positive regulation of peptidyl-serine phosphorylation of STAT proteinGO:003314110.4IFNA2, IFNG
2positive regulation of T cell proliferationGO:004210210.2IFNG, IL2
3defense response to protozoanGO:004283210.1IFNG, IL10
4B cell proliferationGO:004210010.1IFNA2, IL10
5positive regulation of isotype switching to IgG isotypesGO:004830410.1IFNG, IL2
6negative regulation of growth of symbiont in hostGO:004413010.0IFNG, IL10
7antigen processing and presentationGO:001988210.0HLA-B, IFNG
8positive regulation of MHC class II biosynthetic processGO:00453489.9IFNG, IL10
9cell surface receptor signaling pathwayGO:00071669.5CD8A, IFNA2, IFNG
10immune responseGO:00069559.2IFNG, IL10, IL2
11cell-cell signalingGO:00072678.5CCR5, IFNA2, IL10, IL2

Sources for Herpes Zoster

About this section
2CDC
14ExPASy
15FDA
16FMA
24GTR
25HGMD
26HMDB
27ICD10
28ICD10 via Orphanet
29ICD9CM
30IUPHAR
31KEGG
34MedGen
36MeSH
37MESH via Orphanet
38MGI
41NCI
42NCIt
43NDF-RT
46NINDS
47Novoseek
49OMIM
50OMIM via Orphanet
54PubMed
55QIAGEN
60SNOMED-CT via Orphanet
64Tumor Gene Family of Databases
65UMLS
66UMLS via Orphanet